Evidence map›Paper›PMID 28442903›Full record

ArticleInternational journal of nanomedicine2017

Magnetic and pH dual-responsive mesoporous silica nanocomposites for effective and low-toxic photodynamic therapy.

Jieqiong Zhan, Zhiqiang Ma, Dan Wang, Xinfang Li, Xiangui Li, Lijing Le, Anfeng Kang, Pengwei Hu, Lan She, Feng Yang

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma.Frontiers in bioengineering and biotechnology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jieqiong ZhanDepartment of Pharmacy, Hebei North University, Zhangjiakou, Hebei.
Zhiqiang MaDepartment of Inorganic Chemistry, School of Pharmacy.
Dan WangDepartment of Obstetrics and Gynecology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, People's Republic of China.
Xinfang LiDepartment of Inorganic Chemistry, School of Pharmacy.
Xiangui LiDepartment of Inorganic Chemistry, School of Pharmacy.
Lijing LeDepartment of Inorganic Chemistry, School of Pharmacy.
Anfeng KangDepartment of Inorganic Chemistry, School of Pharmacy.
Pengwei HuDepartment of Pharmacy, Hebei North University, Zhangjiakou, Hebei.
Lan SheDepartment of Inorganic Chemistry, School of Pharmacy.
Feng YangDepartment of Pharmacy, Hebei North University, Zhangjiakou, Hebei.
Institute of Inorganic Chemistry of the Slovak Academy of Sciences · SKHebei North University · CNShanghai Changzheng Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonspecific targeting, large doses and phototoxicity severely hamper the clinical effect of photodynamic therapy (PDT). In this work, superparamagnetic Fe

Indexed as

AnimalsApoptosisCell Line, TumorEndocytosisFerrosoferric OxideHydrogen-Ion ConcentrationMagneticsMaleMelanoma, ExperimentalMiceMice, Inbred C57BLNanocompositesNanoparticlesPhotochemotherapyPhotosensitizing AgentsPolyethylene GlycolsFerrosoferric OxidePhotosensitizing Agentspolyethylene glycol-block-polyaspartic acidPolyethylene GlycolsRose BengalRose Bengal BSilicon Dioxidemagnetic mesoporous silicamagnetic targetingphotodynamic therapypH responsivepolymer polyethylene glycol-b-poly(aspartic acid)rose bengal

Identifiers

PMID28442903
PMCPMC5396969
OpenAlexW2606941081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.